EGFR S1166 phosphorylation induced by a combination of EGF and gefitinib has a potentially negative impact on lung cancer cell growth
10.1021/pr3002029
Saved in:
Main Authors: | Assiddiq, B.F., Tan, K.Y., Toy, W., Chan, S.P., Chong, P.K., Lim, Y.P. |
---|---|
Other Authors: | BIOCHEMISTRY |
Format: | Article |
Published: |
2014
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/108358 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
EGF-induced tyrosine phosphorylation of Endofin is dependent on PI3K activity and proper localization to endosomes
by: Toy, W., et al.
Published: (2014) -
Endofin is a novel component in EGR/EGFR oncogenic signaling
by: TOY WEIYI
Published: (2011) -
Evidence for disease control with erlotinib after gefitinib failure in typical gefitinib-sensitive Asian patients with non-small cell lung cancer
by: Wong, A.S., et al.
Published: (2014) -
Rapid determination of gefitinib and its main metabolite, O-desmethyl gefitinib in human plasma using liquid chromatography-tandem mass spectrometry
by: Wang, L.-Z., et al.
Published: (2014) -
Efficacy of dose modification of gefitinib after hepatotoxicity in late-line treatment of EGFR mutated advanced non-small cell lung cancer: A case report
by: Chaichana Chantharakhit
Published: (2019)